Loading clinical trials...
Loading clinical trials...
This study is designed to provide preliminary data to determine if concentrations of piperacillin/tazobactam change in patients with severe respiratory failure receiving extracorporeal membrane oxygen...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Columbia University
NCT04693403 · Acute Respiratory Failure With Hypoxia, Acute Respiratory Distress Syndrome, and more
NCT03326830 · Acute Respiratory Failure With Hypoxia, Oxygen Inhalation Therapy, and more
NCT01937884 · Acute Respiratory Failure With Hypoxia, Malnutrition
NCT04079829 · Respiratory Failure, Respiratory Arrest, and more
NCT04368975 · Acute Respiratory Failure With Hypoxia
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions